The U.S. Food and Drug Administration (FDA) has announced an ambitious effort to modernize drug testing by reducing reliance on animal models in favor of advanced, human-relevant

Zoom in: FDA said its roadmap envisions using computer modeling and AI to predict a drug's behavior and possible side effects, through software simulations of how a monoclonal antibody distributes through the human body.

Several stocks in the health care technology space are moving higher after the market close on Thursday after the U.S. Food and Drug Administration (FDA) announced plans to phase out animal testing requirements.